The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical evaluation of germline polymorphisms (SNPs) associated with capecitabine (C) toxicity (tox) in metastatic breast cancer (MBC).
 
Peter H. O'Donnell
Stock and Other Ownership Interests - DaVita
Honoraria - Abbott Molecular; Dendreon; OptumHealth
Research Funding - Boehringer Ingelheim
Patents, Royalties, Other Intellectual Property - Genomic Prescribing System - Patent Pending
Travel, Accommodations, Expenses - Sequenom
 
Vassily Trubetskoy
No Relationships to Disclose
 
Ashley Nurhussein-Patterson
No Relationships to Disclose
 
Julianne P. Hall
No Relationships to Disclose
 
Dezheng Huo
No Relationships to Disclose
 
Gini F. Fleming
Research Funding - Corcept Therapeutics (Inst)
Other Relationship - Aeterna Zentaris
 
James N. Ingle
No Relationships to Disclose
 
Ingrid A. Mayer
Consulting or Advisory Role - Genentech/Roche; Novartis
Research Funding - Novartis
 
Phuong Khanh H. Morrow
Employment - Amgen
 
Anna Maria Storniolo
Employment - Lilly (I)
 
Andres Forero-Torres
No Relationships to Disclose
 
Catherine H. Van Poznak
Research Funding - Amgen (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate
 
Douglas E. Merkel
No Relationships to Disclose
 
Gary L. Rosner
Stock and Other Ownership Interests - Johnson & Johnson; Pfizer; Walgreens
Honoraria - Novartis
Travel, Accommodations, Expenses - Novartis
 
Olufunmilayo I. Olopade
No Relationships to Disclose
 
Mark J. Ratain
Stock and Other Ownership Interests - AspenBio Pharma; Biscayne Pharmaceuticals
Consulting or Advisory Role - AbbVie; Agios; Biscayne Pharmaceuticals; Cantex Pharmaceuticals; Cerulean Pharma; Cyclacel; Daiichi Sankyo; EMD Serono; Genentech/Roche; Kinex; Onconova Therapeutics; Sanofi; Shionogi; XSpray Microparticles AB
Research Funding - Bristol-Myers Squibb (Inst); Dicerna (Inst); OncoTherapy Science (Inst); PharmaMar (Inst)
Patents, Royalties, Other Intellectual Property - pending patent related to a genomic prescribing system; pending patent related to a genomic prescribing system (Inst); royalties related to UGT1A1 genotyping for irinotecan; royalties related to UGT1A1 genotyping for irinotecan (Inst)
Expert Testimony - Apotex; Fresenius Kabi; Mylan; Teva
 
Nancy Cox
No Relationships to Disclose
 
M. Eileen Dolan
Research Funding - Insys Therapeutics
Expert Testimony - Pfizer
 
Rita Nanda
No Relationships to Disclose